| Physiological Changes in the Critically Ill Patient with Sepsis. | |
| | |
MedLine Citation:
|
PMID: 21554219 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Intensive care medicine deals with the critically ill; these patients usually have multiple organ failure, and complex medical conditions. The mortality in Australia and New Zealand among this population is approximately 16.1%, with approximately 24.2% having existing co-morbidities, and 23.4% of these patients experiencing sepsis or septic shock. Sepsis is a clinical syndrome that traditionally was regarded as a physiological maladaptive response to a foreign pathogen and ranges in disease severity from simple sepsis to septic shock, a life threatening condition, associated with multiple organ failure. Sepsis has profound effects on all systems of the body, and most notably the cardiovascular, renal and hepatic systems. There has been much research into the septic critically ill patient and recent developments in basic pharmacology and physiology has yielded results applicable to clinical practice. Sepsis may induce a state of increased cardiac output, which has significant effects on drug pharmacokinetics and pharmacodynamics. This increased cardiac output increases both renal and hepatic blood flow, and alters rates of antibiotic metabolism, and excretion. There are also alterations in the fluid compartments of the septic critically ill, that results in an altered volume of distribution, and ultimately decreased antibiotic concentrations at their site of action. This article will examine and review in detail the septic critically ill patient, and the effects that sepsis has on physiology and the resulting altered antibiotic pharmacokinetics and pharmacodynamics. Current knowledge suggests that the medical prescriber should be weary of antibiotic dosing in the septic critically ill, and consider alternative dosing regimes that are individualized to the patient in order to maximize efficacy. |
| | |
Authors:
|
Shaun Hosein; Andrew A Udy; Jeffrey Lipman |
Related Documents
:
|
19388909 - The incremental benefit of a shortness-of-breath biomarker panel in emergency departmen... 18807299 - New psych unit eases patient burden in ed. 18211309 - Methamphetamine-related emergency department utilization and cost. 1996819 - Management of acute pyelonephritis in an emergency department observation unit. 11008589 - Characteristics and outcomes of older patients presenting to the emergency department a... 21371299 - The effect of window rooms on critically ill patients admitted to intensive care with s... 20022219 - Impaired decision making in schizophrenia and orbitofrontal cortex lesion patients. 2912619 - Gait analysis in patients with gonarthrosis treated by high tibial osteotomy. 19487739 - A qualitative study of orthognathic patients' perceptions of referral to a mental healt... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-5-10 |
Journal Detail:
|
Title: Current pharmaceutical biotechnology Volume: - ISSN: 1873-4316 ISO Abbreviation: - Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-5-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100960530 Medline TA: Curr Pharm Biotechnol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Staff Specialist, Department of Intensive Care Medicine, Royal Brisbane and Womens Hospital, Herston, Brisbane, 4029, Queensland, Australia. andrew_udy@health.qld.gov.au. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The Relevance of Drug Volume of Distribution in Antibiotic Dosing.
Next Document: Pharmacokinetic Concepts Revisited - Basic and Applied.